StockNews.AI
DDD
StockNews.AI
116 days

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of 3D Systems Corporation - DDD

1. Pomerantz LLP is investigating 3D Systems for potential securities fraud. 2. 3D Systems reported weak Q4 and full-year 2024 financial results. 3. Healthcare revenue dropped 21% due to accounting changes in Regenerative Medicine. 4. Stock price fell 20.96% to $2.15 following disappointing earnings report.

3m saved
Insight
Article

FAQ

Why Very Bearish?

The combination of a significant stock drop and suspected fraud raises concerns. Historical examples show that such investigations can lead to further declines.

How important is it?

The investigation into possible fraud and poor financial results may substantially impact investor confidence and DDD's price.

Why Short Term?

In the short term, heightened scrutiny could lead to continued selling pressure and further volatility.

Related Companies

NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  3D Systems Corporation (“3D Systems” or the “Company”) (NYSE: DDD).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether 3D Systems and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On March 26, 2025, 3D Systems issued a press release announcing its financial results for the fourth quarter and full year 2024. Among other items, 3D Systems reported weak results for the quarter, which missed consensus estimates for sales, operating income, and earnings. 3D systems also reported a 21% drop in Healthcare revenue, largely tied to a change in accounting in its Regenerative Medicine program. On this news, 3D Systems’ stock price fell $0.57 per share, or 20.96%, to close at $2.15 per share on March 27, 2025. Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com. Attorney advertising. Prior results do not guarantee similar outcomes. CONTACT:Danielle PeytonPomerantz LLPdpeyton@pomlaw.com646-581-9980 ext. 7980

Related News